Ying Jin
6PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 05, 2025
An Open-Label, Single-Arm, Phase II Trial of Sintilimab Plus Anlotinib for Metastatic Non-Small Cell Lung Cancer After First-Line PD-(L)1 Inhibitor.Xun Shi, Chen Lin, Lishu Lou
|Dec 20, 2024
Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.Ying Jin, Yuefeng Wu, Alexandre Reuben
|Sep 04, 2024
Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer.Ying Jin, Yuefeng Wu, Alexandre Reuben
|Nov 27, 2023
Small molecule multitarget antiangiogenic inhibitor treatments for advanced thymic epithelial tumors: A retrospective study.Wanji Shen, Ying Jin, Ying Yu
|Oct 06, 2023
PI3K/mTOR inhibitors promote G6PD autophagic degradation and exacerbate oxidative stress damage to radiosensitize small cell lung cancer.Huan Deng, Yamei Chen, Li Wang
Pageof 1